相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips
Kiarach Mesbah et al.
ANALYST (2014)
An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: Application to anti-Alzheimer's drug discovery
Dimitri Brinet et al.
ELECTROPHORESIS (2014)
Biomarkers in Alzheimer's Disease Analysis by Mass Spectrometry-Based Proteomics
Yahui Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments
Simone Lista et al.
JOURNAL OF NEUROLOGY (2014)
Magnetic separation techniques in sample preparation for biological analysis: A review
Jincan He et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Analysis of Amino-Terminal Variants of Amyloid-β Peptides by Capillary Isoelectric Focusing Immunoassay
Ute Haussmann et al.
ANALYTICAL CHEMISTRY (2013)
A new controlled concept of immune-sensing platform for specific detection of Alzheimer's biomarkers
M. Ammar et al.
BIOSENSORS & BIOELECTRONICS (2013)
Development of a high-sensitivity immunoassay for amyloid-beta 1-42 using a silicon microarray platform
Paola Gagni et al.
BIOSENSORS & BIOELECTRONICS (2013)
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
New non-covalent strategies for stable surface treatment of thermoplastic chips
Karla Perez-Toralla et al.
LAB ON A CHIP (2013)
Development of a magnetic immunosorbent for on-chip preconcentration of amyloid β isoforms: Representatives of Alzheimer's disease biomarkers
Zuzana Svobodova et al.
BIOMICROFLUIDICS (2012)
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia
Mirko Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease
Ju-Hee Kang et al.
METHODS (2012)
Quantitation of amyloid beta peptides Aβ1-38, Aβ1-40, and Aβ1-42 in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry
Mary E. Lame et al.
ANALYTICAL BIOCHEMISTRY (2011)
Analysis of Amyloid-β Peptides in Cerebrospinal Fluid Samples by Capillary Electrophoresis Coupled with LIF Detection
Romain Verpillot et al.
ANALYTICAL CHEMISTRY (2011)
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease (vol 118, pg 691, 2011)
Brit Mollenhauer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
THE USE OF MASS SPECTROMETRY TO STUDY AMYLOID-β PEPTIDES
Giuseppe Grasso
MASS SPECTROMETRY REVIEWS (2011)
Identifying and validating biomarkers for Alzheimer's disease
Christian Humpel
TRENDS IN BIOTECHNOLOGY (2011)
Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1-40) and Aβ(1-42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody
Ning Xia et al.
ANALYTICAL CHEMISTRY (2010)
Microchip Electrophoresis Profiling of Aβ Peptides in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
Mohamad Reza Mohamadi et al.
ANALYTICAL CHEMISTRY (2010)
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer's disease
Volker Welge et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease
Romain Verpillot et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease
Neill R. Graff-Radford et al.
ARCHIVES OF NEUROLOGY (2007)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
E Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Safety and acceptability of the research lumbar puncture
ER Peskind et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk et al.
NEUROBIOLOGY OF AGING (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
β-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
J Wiltfang et al.
ANNALS OF NEUROLOGY (2003)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
分享论文
